Scholar Rock to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company, will host a conference call on August 8, 2024, at 8:15am ET to discuss its second quarter 2024 financial results and provide a business update. The call will cover financial performance and advancements in treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases. Interested participants can register for the live audio webcast on the Scholar Rock website under the “Events and Presentations” section. A replay will be available for 90 days.
Scholar Rock (NASDAQ: SRRK), una compagnia biofarmaceutica in fase avanzata, ospiterà una conferenza telefonica l'8 agosto 2024 alle 8:15 ET per discutere i suoi risultati finanziari del secondo trimestre 2024 e fornire un aggiornamento aziendale. La chiamata tratterà le performance finanziarie e i progressi nei trattamenti per la atrofia muscolare spinale (SMA), disordini cardiometabolici e altre gravi malattie. I partecipanti interessati possono registrarsi per il webcast audio dal vivo sul sito web di Scholar Rock nella sezione “Eventi e Presentazioni”. Una registrazione sarà disponibile per 90 giorni.
Scholar Rock (NASDAQ: SRRK), una empresa biofarmacéutica en fase avanzada, llevará a cabo una videoconferencia el 8 de agosto de 2024 a las 8:15 a. m. ET para discutir sus resultados financieros del segundo trimestre de 2024 y proporcionar una actualización empresarial. La llamada abordará el desempeño financiero y los avances en tratamientos para la atrofia muscular espinal (AME), trastornos cardiometabólicos y otras enfermedades graves. Los participantes interesados pueden registrarse para la transmisión de audio en vivo en el sitio web de Scholar Rock en la sección “Eventos y Presentaciones”. Habrá una repetición disponible durante 90 días.
스칼라 록 (NASDAQ: SRRK), 후기 단계의 생물 제약 회사가 2024년 8월 8일 오전 8시 15분 ET에 2024년 2분기 재무 결과 및 사업 업데이트를 논의하기 위해 컨퍼런스 콜을 개최합니다. 이번 전화 회의에서는 척수근위축증 (SMA), 심혈관 대사 질환 및 기타 심각한 질병에 대한 재무 실적과 치료의 발전에 대해 다룰 것입니다. 관심 있는 참가자는 스칼라 록 웹사이트의 “이벤트 및 발표” 섹션에서 라이브 오디오 웹캐스트에 등록할 수 있습니다. 녹화는 90일 동안 제공될 예정입니다.
Scholar Rock (NASDAQ: SRRK), une société biopharmaceutique en phase avancée, organisera une conférence téléphonique le 8 août 2024 à 8h15 ET pour discuter de ses résultats financiers du deuxième trimestre 2024 et fournir une mise à jour d'entreprise. L'appel couvrira la performance financière et les avancées dans les traitements pour l'atrophie musculaire spinale (AMS), les troubles cardiométaboliques et d'autres maladies graves. Les participants intéressés peuvent s'inscrire pour le webinaire audio en direct sur le site web de Scholar Rock dans la section “Événements et présentations”. Un enregistrement sera disponible pendant 90 jours.
Scholar Rock (NASDAQ: SRRK), ein Unternehmen der späten Phase der Biopharmazeutik, wird am 8. August 2024 um 8:15 Uhr ET eine Telefonkonferenz abhalten, um über die finanziellen Ergebnisse des zweiten Quartals 2024 zu berichten und ein Geschäftsupdate zu geben. Während des Anrufs werden die finanzielle Performance sowie Fortschritte in der Behandlung von spinaler Muskelatrophie (SMA), kardiometabolischen Störungen und anderen schweren Krankheiten behandelt. Interessierte Teilnehmer können sich auf der Website von Scholar Rock im Bereich „Veranstaltungen und Präsentationen“ für das Live-Audio-Webcast registrieren. Eine Wiederholung wird 90 Tage lang verfügbar sein.
- Upcoming financial results and business update could provide insights into new developments and company growth.
- None.
To access the live conference call, participants may register here. The live audio webcast of the call will be available under “Events and Presentations” in the Investor Relations section of the Scholar Rock website at http://investors.scholarrock.com. To participate via telephone, please register in advance here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. An archived replay of the webcast will be available on the Company’s website for approximately 90 days.
About Scholar Rock
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, Scholar Rock has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.
Scholar Rock is the only company to show clinical proof-of-concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about our approach at ScholarRock.com and follow @ScholarRock and on LinkedIn.
Scholar Rock® is a registered trademark of Scholar Rock, Inc.
Availability of Other Information About Scholar Rock
Investors and others should note that we communicate with our investors and the public using our company website www.scholarrock.com, including, but not limited to, company disclosures, investor presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference call transcripts and webcast transcripts, as well as on Twitter and LinkedIn. The information that we post on our website or on Twitter or LinkedIn could be deemed to be material information. As a result, we encourage investors, the media and others interested to review the information that we post there on a regular basis. The contents of our website or social media shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.
Scholar Rock® is a registered trademark of Scholar Rock, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240723832080/en/
Scholar Rock:
Investors
Rushmie Nofsinger
Scholar Rock
rnofsinger@scholarrock.com
ir@scholarrock.com
857-259-5573
Media
Molly MacLeod
Scholar Rock
mmacleod@scholarrock.com
media@scholarrock.com
802-579-5995
Source: Scholar Rock
FAQ
When will Scholar Rock discuss its second quarter 2024 financial results?
How can I access the Scholar Rock second quarter 2024 financial results conference call?
Will there be an archived replay of the Scholar Rock second quarter 2024 earnings call?
What topics will be covered in the Scholar Rock conference call on August 8, 2024?
